研究表明,GLP-1受体激动剂和GIP药物使酒精和阿片成瘾分别减少50%和40%。 Study shows GLP-1 receptor agonists and GIP drugs reduce alcohol and opioid addiction by 50% and 40%, respectively.

期刊《成瘾》发表的一项研究表明,减重和糖尿病药物,特别是GLP-1受体激动剂,如Ozempic和Mounjaro等GIP药物,可能有助于减少酒精和阿片成瘾。 A study published in the journal Addiction indicates that weight loss and diabetes medications, specifically GLP-1 receptor agonists like Ozempic and GIP drugs like Mounjaro, may help reduce alcohol and opioid addiction. 研究人员发现,这些药物使用者中酒精中毒减少50%,阿片类药物过量减少40%。 Researchers found a 50% decrease in alcohol intoxication and a 40% reduction in opioid overdose among users of these medications. 调查结果表明,有必要进一步调查它们作为药物使用紊乱治疗方案的潜力。 The findings suggest further investigation into their potential as treatment options for substance use disorders is warranted.